ARTICLE | Clinical News
Clonidine: Phase III data
April 6, 2015 7:00 AM UTC
The double-blind, U.S. Phase III RHAPSODY trial in about 260 patients with painful diabetic neuropathy showed that clonidine topical gel missed the primary endpoint of improving average NPRS score fro...